EE03492B1 - Mitte-autoinaktiveeruvad ekspressiooni suunavad retroviiruslikud vektorid - Google Patents

Mitte-autoinaktiveeruvad ekspressiooni suunavad retroviiruslikud vektorid

Info

Publication number
EE03492B1
EE03492B1 EE9700040A EE9700040A EE03492B1 EE 03492 B1 EE03492 B1 EE 03492B1 EE 9700040 A EE9700040 A EE 9700040A EE 9700040 A EE9700040 A EE 9700040A EE 03492 B1 EE03492 B1 EE 03492B1
Authority
EE
Estonia
Prior art keywords
region
auto
retroviral vectors
direct expression
inactivating retroviral
Prior art date
Application number
EE9700040A
Other languages
English (en)
Estonian (et)
Other versions
EE9700040A (et
Inventor
Henry G�nzburg Walter
Michael Saller Robert
Original Assignee
GSF-Forschungszentrum f�r Umwelt und Gesundheit GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GSF-Forschungszentrum f�r Umwelt und Gesundheit GmbH filed Critical GSF-Forschungszentrum f�r Umwelt und Gesundheit GmbH
Publication of EE9700040A publication Critical patent/EE9700040A/xx
Publication of EE03492B1 publication Critical patent/EE03492B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Ceramic Products (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Traffic Control Systems (AREA)
  • Navigation (AREA)
  • Road Signs Or Road Markings (AREA)
  • Molds, Cores, And Manufacturing Methods Thereof (AREA)
  • Optical Radar Systems And Details Thereof (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
EE9700040A 1994-09-02 1995-09-01 Mitte-autoinaktiveeruvad ekspressiooni suunavad retroviiruslikud vektorid EE03492B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK101794 1994-09-02
PCT/EP1995/003445 WO1996007748A1 (en) 1994-09-02 1995-09-01 Non self-inactivating, expression targeted retroviral vectors

Publications (2)

Publication Number Publication Date
EE9700040A EE9700040A (et) 1997-08-15
EE03492B1 true EE03492B1 (et) 2001-08-15

Family

ID=8100062

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700040A EE03492B1 (et) 1994-09-02 1995-09-01 Mitte-autoinaktiveeruvad ekspressiooni suunavad retroviiruslikud vektorid

Country Status (21)

Country Link
US (1) US7531353B1 (xx)
EP (1) EP0779929B1 (xx)
JP (1) JP4037446B2 (xx)
CN (1) CN1117156C (xx)
AT (1) ATE200517T1 (xx)
AU (1) AU688590B2 (xx)
BR (1) BR9508664A (xx)
CA (1) CA2198210C (xx)
DE (1) DE69520681T2 (xx)
DK (1) DK0779929T5 (xx)
EE (1) EE03492B1 (xx)
ES (1) ES2156945T3 (xx)
FI (1) FI970892A (xx)
HK (1) HK1001527A1 (xx)
HU (1) HU221607B (xx)
MX (1) MX9701544A (xx)
NO (1) NO317731B1 (xx)
NZ (1) NZ292897A (xx)
PL (1) PL184375B1 (xx)
RU (1) RU2199585C2 (xx)
WO (1) WO1996007748A1 (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU688590B2 (en) 1994-09-02 1998-03-12 Gsf - Forschungszentrum Fur Umwelt Und Gesundheit Gmbh Non self-inactivating, expression targeted retroviral vectors
EP0817858B1 (en) * 1995-03-09 2003-04-23 Austrian Nordic Biotherapeutics AG Vectors carrying therapeutic genes encoding antimicrobial peptides for gene therapy
CN1187095C (zh) 1995-06-27 2005-02-02 巴法里安诺迪克有限公司 可生产病毒颗粒的被囊化细胞
ES2176500T3 (es) * 1995-10-13 2002-12-01 Austrian Nordic Biotherapeutic Vectores retroviricos que llevan inhibidores 1 derivados de celulas senescentes (sdi-1) o secuencias de nucleotidos antisentido de sdi-1.
US7074398B1 (en) 1995-10-13 2006-07-11 Gsf-Forschungszentrum Fuer Umwelt Und Gesundheit Gmbh Retroviral vectors carrying senescent cell derived inhibitors 1 (SDI-1)or antisense SDI-1 nucleotide sequences
US6540995B1 (en) 1996-03-27 2003-04-01 Bavarian Nordic Research Institute Gmbh Encapsulated cells producing cytochrome P450
SI0892852T1 (sl) 1996-03-27 2006-04-30 Bavarian Nordic As Inkapsulirane celice, ki eksprimirajo citokrom P450 za aktiviranje predzdravila
WO1998032869A1 (en) * 1997-01-29 1998-07-30 Neurosearch A/S Expression vectors and methods for in vivo expression of therapeutic polypeptides
CN1322137C (zh) * 1997-12-22 2007-06-20 牛津生物医学（英国）有限公司 基于马传染性贫血病毒(eiav)的逆转录病毒载体
EP1045922B1 (en) 1998-01-06 2004-09-29 Institut für Virologie Teilrechtsfähiges Institut an der Veterinärmedizinischen Universität Wien Reconstituting retroviral vector (recon vector) for targeted gene expression
FR2778670B1 (fr) * 1998-05-18 2002-12-13 Rhone Poulenc Rorer Sa Methodes et compositions pour la production de particules virales
DE19910650A1 (de) * 1999-03-10 2000-09-21 Gsf Forschungszentrum Umwelt Auf HERV-LTR-Sequenzen basierende retrovirale Expressionsvektoren
EP1173597A1 (en) * 1999-04-29 2002-01-23 Aarhus University Expression of heterologous genes from an ires translational cassette in retroviral vectors
WO2002064805A2 (en) * 2001-02-09 2002-08-22 Institut für Virologie Teilrechtsfähiges Institut an der Veterinärmedizinischen Universität Wien Replication competent non-mammalian retroviral vectors
DE102009021592A1 (de) * 2009-05-15 2010-11-18 Medizinische Hochschule Hannover ASLV-Vektorsystem

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE142268T1 (de) 1988-05-17 1996-09-15 Sloan Kettering Inst Cancer Retroviraler vektor
GB8919607D0 (en) * 1989-08-30 1989-10-11 Wellcome Found Novel entities for cancer therapy
WO1994029437A1 (en) * 1993-06-07 1994-12-22 University Of Medicine & Dentistry Of New Jersey Highly-efficient, self-inactivating, recombination-free, u3-free retroviral vectors
AU688590B2 (en) 1994-09-02 1998-03-12 Gsf - Forschungszentrum Fur Umwelt Und Gesundheit Gmbh Non self-inactivating, expression targeted retroviral vectors
ATE212061T1 (de) * 1995-03-09 2002-02-15 Austrian Nordic Biotherapeutic Rekombinante dna-vektoren für die gentherapie
EP0817858B1 (en) * 1995-03-09 2003-04-23 Austrian Nordic Biotherapeutics AG Vectors carrying therapeutic genes encoding antimicrobial peptides for gene therapy
US6117681A (en) * 1995-03-29 2000-09-12 Bavarian Nordic Research Inst. A/S Pseudotyped retroviral particles
GB9510272D0 (en) 1995-05-22 1995-07-19 Isis Innovation Retroviral vectors
US7074398B1 (en) * 1995-10-13 2006-07-11 Gsf-Forschungszentrum Fuer Umwelt Und Gesundheit Gmbh Retroviral vectors carrying senescent cell derived inhibitors 1 (SDI-1)or antisense SDI-1 nucleotide sequences

Also Published As

Publication number Publication date
CA2198210A1 (en) 1996-03-14
JP4037446B2 (ja) 2008-01-23
PL184375B1 (pl) 2002-10-31
MX9701544A (es) 1998-03-31
DK0779929T5 (da) 2001-08-13
DK0779929T3 (da) 2001-05-07
NO970902D0 (no) 1997-02-27
BR9508664A (pt) 1998-01-06
DE69520681T2 (de) 2001-11-29
EP0779929B1 (en) 2001-04-11
WO1996007748A1 (en) 1996-03-14
ES2156945T3 (es) 2001-08-01
NO317731B1 (no) 2004-12-13
AU688590B2 (en) 1998-03-12
FI970892A0 (fi) 1997-02-28
NZ292897A (en) 1998-08-26
NO970902L (no) 1997-04-24
RU2199585C2 (ru) 2003-02-27
CN1117156C (zh) 2003-08-06
DE69520681D1 (de) 2001-05-17
AU3520195A (en) 1996-03-27
HK1001527A1 (en) 1998-06-26
CA2198210C (en) 2006-07-11
EE9700040A (et) 1997-08-15
FI970892A (fi) 1997-02-28
JPH10507628A (ja) 1998-07-28
HUT76974A (hu) 1998-01-28
HU221607B (hu) 2002-11-28
PL319033A1 (en) 1997-07-21
ATE200517T1 (de) 2001-04-15
CN1159210A (zh) 1997-09-10
US7531353B1 (en) 2009-05-12
EP0779929A1 (en) 1997-06-25

Similar Documents

Publication Publication Date Title
EE03492B1 (et) Mitte-autoinaktiveeruvad ekspressiooni suunavad retroviiruslikud vektorid
WO1998039463A3 (en) Lentivirus based vector and vector system
TR199802695T2 (xx) IL-8 Resept�r kar��tlar�
NO953462L (no) Heterosykliske forbindelser og deres fremstilling og anvendelse
ATE206409T1 (de) N-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1-h- benzo(b)(1,5)-diazepin-3-yl)-acetamide
DE69233785D1 (de) diert
EE04378B1 (xx) LAG-3 pleissimisteisendid
ES2193241T3 (es) Nuevas n-2-oxo2.3.4.5-tetrajodrp-1h-1,5-benzodiazepin-3-il)-3-amidas.
DE59509910D1 (de) Verfahren zur Herstellung von Alkylhydrogenchlorsilanen
DE60237791D1 (de) Zytokinproteinfamilie
ES2194102T3 (es) Nuevas n-(2,4-dioxo-2,3,4,5-tetrahidro-1h-1,5-benzodiazepin-3-il)-3-amidas.
CA2267945A1 (en) Anticonvulsant derivatives useful in treating neuropathic pain
DE59109072D1 (de) Klonierung der N-Methylhydantoinase
ID20153A (id) Proses polimerisasi etilena dengan adanya suatu katalis kromium oksida
ATE89005T1 (de) Rekombinantes vektorsystem fuer metalloproteinase- inhibitorsequenz und dessen verwendung und herstellung nach dem rekombinant-dns-verfahren.
MX9605731A (es) Preparacion de un catalizador de hidratacion con empleo de m(or)mxn.
GR82440B (xx)
UA20042A (uk) Біс-n,n-диметил-n-(2-гідрокси-3-бутоксипропіл) аміhо-ізо-фталімід як латеhтhий каталізатор отвердіhhя епоксидhих композицій
UA20041A (uk) Біс-n,n-диметил-n-(2-гідрокси-3-бутоксипропіл) аміhоадипоілімід як латеhтhий каталізатор отвердіhhя епоксидhих композицій
DE59109126D1 (de) N-Carbamoylsarcosin-Amidohydrolase, kloniert
MX9707249A (es) Catalizador y proceso para la hidrogenacion de olefinas o polimeros.
DE69729098D1 (de) Fluorierung von ketoamiden
MX9605938A (es) Promotor de actinomicetos.

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20110901